News

An FDA-cleared predictive analytic tool for hemodynamic instability may soon leverage its success in critical care to the ...
When the U.S. Food and Drug Administration (FDA) convened a public expert panel to review the use of selective serotonin ...
The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.
An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts ...
The Food and Drug Administration is shifting its annual COVID-19 vaccine approval policies to focus on Americans older than age 65 and other "high-risk" individuals, while increasing the standard ...
The FDA will prioritize approval of COVID-19 vaccines which can be proven to generate antibody titers in people over age 65 or people who are 6 months or older and at high risk for severe disease ...
In a major policy change, the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots only to people over 65 years old or those with an underlying health condition.
The FDA subsequently issued is Class I risk classification on July 3. Vita Warehouse Corp. issued a voluntary recall for more than 40,000 bottles of Vitamin B12 supplements on June 12 because of ...
The FDA announced Tuesday that, going forward, COVID-19 vaccines would be approved only for people over age 65 or those at risk for severe infection.. The move will streamline the approach to ...
Ginger Beer Recall Update as FDA Issues Highest Risk Warning. Published Jun 19, 2025 at 10:04 AM EDT. By . Jasmine Laws is a US News Reporter at Newsweek based in London, U.K.
The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over the age of 65 years and for all persons above the age of 6 months with ...